Stock RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Reviva Pharmaceuticals Holdings, Inc.

Equities

RVPH

US76152G1004

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
2.9 USD -3.01% Intraday chart for Reviva Pharmaceuticals Holdings, Inc. -6.15% -43.69%
Apr. 15 Reviva Pharmaceuticals Holdings, Inc. Gains Alignment with U.S. Food and Drug Administration on its Registrational Phase 3 Program for Brilaroxazine in Schizophrenia CI
Apr. 15 Reviva Pharmaceuticals Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on Reviva Pharmaceuticals Holdings, Inc.

Price target over the last 5 years

History of analyst recommendation changes

7dc0ecde2888c27eb242b5218.-Kxw5LR5av9JVDWN_YhI0FLUxUNkYXdDHuVIlYEj-4s.q5szi9UfG8t5GmHHiv4f4mGWpABRJDYvJ4t51NRCo--w5gK-3jJatQQkQg~0dc20c5f28ad7f8fa21038a709faef1b

Analyst Recommendations on Reviva Pharmaceuticals Holdings, Inc.

HC Wainwright Raises Reviva Pharmaceuticals' Price Target to $20 From $10, Keeps Buy Rating MT
Roth MKM Initiates Reviva Pharmaceuticals With Buy Rating, Price Target is $12 MT
Benchmark Initiates Reviva Pharmaceuticals at Speculative Buy With $17 Price Target MT
Maxim Adjusts Price Target on Reviva Pharmaceuticals Holdings to $18 From $10, Maintains Buy Rating MT
Fed Rate Increase Drags Exchange-Traded Funds, Stock Futures Lower Premarket Thursday MT
Alliance Global Starts Reviva Pharmaceuticals Holdings at Buy With $16 Price Target MT
Maxim Group Adjusts Price Target on Reviva Pharmaceuticals Holdings to $10 From $3, Maintains Buy Rating MT
Maxim Lowers Price Target for Reviva Pharmaceuticals Holdings to $3 From $5, Maintains Buy Rating MT
HC Wainwright Starts Reviva Pharmaceuticals Holdings at Buy With $10 Price Target MT
Today on Wall Street: More rate hikes expected this year Our Logo
REVIVA PHARMACEUTICALS : Maxim Group Initiates Reviva Pharmaceuticals at Buy Rating With $10 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.99 USD
Average target price
17.4 USD
Spread / Average Target
+481.94%
High Price Target
20 USD
Spread / Highest target
+568.90%
Low Price Target
16 USD
Spread / Lowest Target
+435.12%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Reviva Pharmaceuticals Holdings, Inc.

HC Wainwright
Roth MKM
Benchmark Company
Maxim
Alliance Global Partners

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. RVPH Stock
  4. Consensus Reviva Pharmaceuticals Holdings, Inc.